Banks, Drugs & CES

Bank stocks have been rallying, with investors shrugging off concerns about commercial real estate loans and net interest margin pressures even as bank analysts cut 2024 revenue and earnings estimates. Will big banks’ Q4 earnings reports Friday change the narrative? … Also: Several forces look poised to disrupt pharmaceutical pricing. Besides Medicare’s newly bestowed negotiation powers, Florida plans to save big bucks by importing drugs from Canada and innovative new business models cut out the middle man to lower the drug prices offered to consumers. … And: Jackie highlights intriguing new technologies unveiled at this year’s CES convention.